Innventure risk analysis
Want to see INV full AI Analyst Report?
Innventure (INV) Risk Analysis
Risk Overview Q3, 2026
Source: the company's latest filing for the period ended Sep 30, 2026, filed Nov 12, 2026
Risk Change Over Time
- Share Price & Shareholder Rights - Risk 1We have a limited number of shares available for future awards under our equity incentive plan, which may be insufficient to satisfy our compensation obligations to our employees and directors and could impair our ability to attract, retain and motivate key personnel and directors.
As of November 6, 2026 approximately 1.0 million shares of Common Stock remained available for future awards under our 2024 Equity and Incentive Compensation Plan, after taking into account estimated director compensation for the fourth quarter of 2026. The number of shares required to deliver awards of a given value increases as the trading price of our Common Stock declines, and a portion of our non-employee director compensation is paid in shares of Common Stock. If the shares available under the plan are insufficient, we may be unable to satisfy our existing obligations to deliver equity compensation to our employees and non-employee directors, including the portion of non-employee director compensation payable in shares of Common Stock, which could expose us to claims, and we may be unable to grant equity awards at levels we consider necessary to attract, retain and motivate our executive officers, employees and directors, particularly during a period of leadership transition and strategic review. Increasing the number of shares available under the plan would require stockholder approval, which we may not obtain. If we instead pay cash in place of shares we are obligated to deliver or awards we would otherwise grant, our cash requirements would increase, which could adversely affect our liquidity. Any additional shares issued under the plan would also dilute our existing stockholders.
- Share Price & Shareholder Rights - Risk 2Sales of a substantial number of shares of our Common Stock, or the perception that such sales may occur, may impair our ability to raise capital.
Sales of a substantial number of shares of our Common Stock or other equity-related securities in the public markets could depress the market price of our Common Stock. Sales under the Sales Agreement may contribute to a depressed market price of our Common Stock. Such sales also may impair our ability to raise capital through the sale of additional equity securities in the future at a time and price that our management deems acceptable, if at all. In addition, the 2024 WTI Warrants and the 2025 WTI Warrants contain anti-dilution provisions that could result in a significant increase in the number of shares of Common Stock issuable upon exercise of those warrants in connection with future offerings. Under those warrants, the holders may elect to have the warrants become exercisable for shares of equity securities issued in any equity financing in which we receive gross cash proceeds of at least $10.0 million, at a per share price equal to the lowest price per share paid by any purchaser in that financing, rather than at the current exercise price. Because the number of shares issuable upon exercise is determined by dividing each warrant's coverage amount by the applicable exercise price, a lower offering price per share in a future offering would result in a correspondingly larger number of shares issuable to the WTI Lenders upon exercise of their warrants. There can be no assurance that we will obtain a waiver of these provisions for future offerings, including sales under the Sales Agreement, and, if we do not obtain such a waiver, these anti-dilution rights could result in a material increase in the number of shares of Common Stock issuable to the WTI Lenders and corresponding additional dilution to our stockholders.
- Share Price & Shareholder Rights - Risk 3If, in the future, we cease to control and operate the Innventure Companies, our status under the Investment Company Act could be adversely affected.
A significant factor in our not being deemed an investment company under the Investment Company Act is the fact that we operate and/or control each of the Innventure Companies. Depending upon the then existing facts and circumstances, a future change where we do not operate and/or control a particular Innventure Company could adversely impact our status as other than an investment company under the Investment Company Act. If we were deemed to be an investment company, we could have to register as an investment company under the Investment Company Act, obtain exemptive relief from the SEC, or modify our organizational structure or our contract rights to fall outside the definition of an investment company. Registering as an investment company could, among other things, materially adversely affect our financial condition, business and results of operations, as described above.
- Share Price & Shareholder Rights - Risk 4We have received a notice from Nasdaq that we do not satisfy its Bid Price Requirement. If we are unable to regain compliance, our Common Stock could be delisted, which could adversely affect the liquidity and trading price of our Common Stock and our ability to raise capital.
Our Common Stock is listed on The Nasdaq Global Market. To maintain that listing, we must satisfy the continued listing requirements of The Nasdaq Stock Market LLC ("Nasdaq"), including a minimum bid price of $1.00 per share. On October 23, 2026, we received a letter from the Listing Qualifications Department of Nasdaq notifying us that, for the 30 consecutive business days ended October 22, 2026, the closing bid price of our Common Stock was below $1.00 per share, which is the Bid Price Requirement. The letter did not result in the immediate delisting of our Common Stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have until April 21, 2027 to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. If we do not regain compliance by that date, we may be eligible for an additional 180 calendar day compliance period if we apply to transfer the listing of our Common Stock to The Nasdaq Capital Market, satisfy the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (other than the Bid Price Requirement). We must also provide written notice to Nasdaq of our intention to cure the deficiency. We may not qualify for an additional compliance period, and Nasdaq may not grant one. In addition, if the closing bid price of our Common Stock is $0.10 or less for ten consecutive business days, whether or not we are then in a compliance period, Nasdaq will issue a delisting determination and our Common Stock will be immediately suspended from trading on Nasdaq. A request for a hearing before a Nasdaq Hearings Panel would not stay the suspension, and our Common Stock would likely trade over-the-counter while any appeal is pending. Nasdaq rules also limit the availability of a compliance period for a company that has effected a reverse stock split within the prior year, or that has effected reverse stock splits over the prior two years with a cumulative ratio of 250 shares or more to one, so a reverse stock split undertaken to regain compliance could limit our ability to obtain a compliance period for any future bid price deficiency. We intend to monitor the closing bid price of our Common Stock and consider available options to regain compliance. We may consider a reverse stock split to regain compliance, which would require stockholder approval and may not result in a sustained increase in the trading price of our Common Stock. However, there can be no assurance that we will regain compliance with the Bid Price Requirement during the initial compliance period or any additional compliance period, or that we will maintain compliance with Nasdaq's other continued listing requirements. Even if we regain compliance with the Bid Price Requirement, we may fail to satisfy it, or another continued listing requirement, in the future. If our Common Stock is delisted from Nasdaq, our stockholders could face material adverse consequences, including a limited trading market for our Common Stock, reduced liquidity, a determination that our Common Stock is a "penny stock," which would subject broker-dealers trading in our Common Stock to additional rules and could reduce trading activity, decrease analyst coverage and reduce investor interest. A delisting could also materially impair our ability to raise capital, including through sales of Common Stock under the Sales Agreement, and could result in negative publicity. Any of these consequences could have a material adverse effect on our business, financial condition, results of operations and ability to continue as a going concern.
- Debt & Financing - Risk 5Each of AeroFlexx and Refinity may be required to wind up or cease operations if it cannot obtain other funding.
We are pursuing strategic alternatives for AeroFlexx and Refinity, including potential sales and interim third-party financings. If either company is unable to obtain sufficient funding from other sources, it may be required to wind up or cease operations and may be unable to continue as a going concern. In that event, we may realize little or no value from our interest in that company, and we could incur additional impairment charges, write-offs of intercompany advances and other costs and liabilities associated with a wind-down.
- Corporate Activity and Growth - Risk 6Our Board has formed a Strategic Review Committee to evaluate capital strategies and other strategic matters, and the review may not result in any transaction or enhance stockholder value.
In September 2026, our Board formed a Strategic Review Committee of independent directors comprised solely of directors who do not have any direct interest in any of the Company's operating companies to oversee a range of strategic matters, including an evaluation of capital strategies. This committee is working with RBC Capital Markets, LLC. No timetable has been set for the conclusion of the review, and no decisions have been made regarding potential actions. The outcome will depend on factors beyond our control, including market conditions, the trading price of our Common Stock, the availability of counterparties and financing on acceptable terms, and consents, approvals or waivers that may be required from the WTI Lenders under the WTI Facility or from other equityholders of the Innventure Companies. Any transaction could dilute our stockholders or our interests in the Innventure Companies, including Accelsius, which has engaged a financial advisor in connection with evaluating its private capital formation needs and alternatives. The review will require significant management attention and professional fees whether or not a transaction is completed, and speculation about its outcome could cause the trading price of our Common Stock to fluctuate significantly.
Risk Highlights Q3, 2026
Risk Factors Full Breakdown - Total Risks 49
- Share Price & Shareholder Rights - Risk 1AddedWe have a limited number of shares available for future awards under our equity incentive plan, which may be insufficient to satisfy our compensation obligations to our employees and directors and could impair our ability to attract, retain and motivate key personnel and directors.
As of November 6, 2026 approximately 1.0 million shares of Common Stock remained available for future awards under our 2024 Equity and Incentive Compensation Plan, after taking into account estimated director compensation for the fourth quarter of 2026. The number of shares required to deliver awards of a given value increases as the trading price of our Common Stock declines, and a portion of our non-employee director compensation is paid in shares of Common Stock. If the shares available under the plan are insufficient, we may be unable to satisfy our existing obligations to deliver equity compensation to our employees and non-employee directors, including the portion of non-employee director compensation payable in shares of Common Stock, which could expose us to claims, and we may be unable to grant equity awards at levels we consider necessary to attract, retain and motivate our executive officers, employees and directors, particularly during a period of leadership transition and strategic review. Increasing the number of shares available under the plan would require stockholder approval, which we may not obtain. If we instead pay cash in place of shares we are obligated to deliver or awards we would otherwise grant, our cash requirements would increase, which could adversely affect our liquidity. Any additional shares issued under the plan would also dilute our existing stockholders.
- Share Price & Shareholder Rights - Risk 2AddedSales of a substantial number of shares of our Common Stock, or the perception that such sales may occur, may impair our ability to raise capital.
Sales of a substantial number of shares of our Common Stock or other equity-related securities in the public markets could depress the market price of our Common Stock. Sales under the Sales Agreement may contribute to a depressed market price of our Common Stock. Such sales also may impair our ability to raise capital through the sale of additional equity securities in the future at a time and price that our management deems acceptable, if at all. In addition, the 2024 WTI Warrants and the 2025 WTI Warrants contain anti-dilution provisions that could result in a significant increase in the number of shares of Common Stock issuable upon exercise of those warrants in connection with future offerings. Under those warrants, the holders may elect to have the warrants become exercisable for shares of equity securities issued in any equity financing in which we receive gross cash proceeds of at least $10.0 million, at a per share price equal to the lowest price per share paid by any purchaser in that financing, rather than at the current exercise price. Because the number of shares issuable upon exercise is determined by dividing each warrant's coverage amount by the applicable exercise price, a lower offering price per share in a future offering would result in a correspondingly larger number of shares issuable to the WTI Lenders upon exercise of their warrants. There can be no assurance that we will obtain a waiver of these provisions for future offerings, including sales under the Sales Agreement, and, if we do not obtain such a waiver, these anti-dilution rights could result in a material increase in the number of shares of Common Stock issuable to the WTI Lenders and corresponding additional dilution to our stockholders.
- Share Price & Shareholder Rights - Risk 3AddedIf, in the future, we cease to control and operate the Innventure Companies, our status under the Investment Company Act could be adversely affected.
A significant factor in our not being deemed an investment company under the Investment Company Act is the fact that we operate and/or control each of the Innventure Companies. Depending upon the then existing facts and circumstances, a future change where we do not operate and/or control a particular Innventure Company could adversely impact our status as other than an investment company under the Investment Company Act. If we were deemed to be an investment company, we could have to register as an investment company under the Investment Company Act, obtain exemptive relief from the SEC, or modify our organizational structure or our contract rights to fall outside the definition of an investment company. Registering as an investment company could, among other things, materially adversely affect our financial condition, business and results of operations, as described above.
- Share Price & Shareholder Rights - Risk 4ChangedThe price of our Common Stock may be volatile.
The market price of our Common Stock may fluctuate substantially. For example, from January 1, 2026 through November 9, 2026, the closing price of our Common Stock fluctuated from $0.14 to $7.32. The price of our Common Stock may be higher or lower than the price that you have paid, depending on many factors, some of which are beyond our control and may not be related to our operating performance. Stock market volatility may also adversely affect the trading price of our Common Stock. In the past, following periods of volatility in the market price of a company's securities, stockholders have often instituted class action securities litigation against those companies, such as the putative securities class action complaint captioned Labed v. Innventure, Inc., et al., Case No. 1:26-cv-07377, filed on August 28, 2026 in the United States District Court for the Southern District of New York against the Company and certain of its current and former executive officers. Such litigation could result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation.
- Share Price & Shareholder Rights - Risk 5AddedWe have received a notice from Nasdaq that we do not satisfy its Bid Price Requirement. If we are unable to regain compliance, our Common Stock could be delisted, which could adversely affect the liquidity and trading price of our Common Stock and our ability to raise capital.
Our Common Stock is listed on The Nasdaq Global Market. To maintain that listing, we must satisfy the continued listing requirements of The Nasdaq Stock Market LLC ("Nasdaq"), including a minimum bid price of $1.00 per share. On October 23, 2026, we received a letter from the Listing Qualifications Department of Nasdaq notifying us that, for the 30 consecutive business days ended October 22, 2026, the closing bid price of our Common Stock was below $1.00 per share, which is the Bid Price Requirement. The letter did not result in the immediate delisting of our Common Stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have until April 21, 2027 to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. If we do not regain compliance by that date, we may be eligible for an additional 180 calendar day compliance period if we apply to transfer the listing of our Common Stock to The Nasdaq Capital Market, satisfy the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (other than the Bid Price Requirement). We must also provide written notice to Nasdaq of our intention to cure the deficiency. We may not qualify for an additional compliance period, and Nasdaq may not grant one. In addition, if the closing bid price of our Common Stock is $0.10 or less for ten consecutive business days, whether or not we are then in a compliance period, Nasdaq will issue a delisting determination and our Common Stock will be immediately suspended from trading on Nasdaq. A request for a hearing before a Nasdaq Hearings Panel would not stay the suspension, and our Common Stock would likely trade over-the-counter while any appeal is pending. Nasdaq rules also limit the availability of a compliance period for a company that has effected a reverse stock split within the prior year, or that has effected reverse stock splits over the prior two years with a cumulative ratio of 250 shares or more to one, so a reverse stock split undertaken to regain compliance could limit our ability to obtain a compliance period for any future bid price deficiency. We intend to monitor the closing bid price of our Common Stock and consider available options to regain compliance. We may consider a reverse stock split to regain compliance, which would require stockholder approval and may not result in a sustained increase in the trading price of our Common Stock. However, there can be no assurance that we will regain compliance with the Bid Price Requirement during the initial compliance period or any additional compliance period, or that we will maintain compliance with Nasdaq's other continued listing requirements. Even if we regain compliance with the Bid Price Requirement, we may fail to satisfy it, or another continued listing requirement, in the future. If our Common Stock is delisted from Nasdaq, our stockholders could face material adverse consequences, including a limited trading market for our Common Stock, reduced liquidity, a determination that our Common Stock is a "penny stock," which would subject broker-dealers trading in our Common Stock to additional rules and could reduce trading activity, decrease analyst coverage and reduce investor interest. A delisting could also materially impair our ability to raise capital, including through sales of Common Stock under the Sales Agreement, and could result in negative publicity. Any of these consequences could have a material adverse effect on our business, financial condition, results of operations and ability to continue as a going concern.
- Share Price & Shareholder Rights - Risk 6The determination as to whether certain Innventure assets are viewed as securities (i.e., by falling within the definition of an "investment contract") is made by Innventure and if the SEC were to disagree with Innventure's determination, Innventure could be deemed to be an investment company under the Investment Company Act.
Section 3(a)(1)(A) of the Investment Company Act defines an "investment company" to include a company that "is or holds itself out as being engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting or trading in securities." Whether a company is engaged primarily in the business of investing in securities is a question of fact that is determined through the analysis of five factors. No single factor by itself is dispositive. The relevant factors are: (1) the nature of a company's assets; (2) the source of a company's income; (3) the company's historic development; (4) the company's public representations; and (5) the activities of the company's officers and directors. In the context of its Section 3(a)(1)(A) analysis, and specifically Section 3(a)(1)(A)'s asset test, Innventure has determined that neither Innventure's equity interest in AeroFlexx nor the loans from Innventure to AeroFlexx are a "security." This determination is based upon Innventure's conclusion that neither should be viewed as an "investment contract." Applicable case law has found that an "investment contract" exists when there is the investment of money in a common enterprise with a reasonable expectation of profits to be derived primarily from the efforts of others. The above determinations were made by Innventure based in large part on case law precedent and no-action letters issued by the SEC staff and other SEC interpretive guidance, and the significant relationship that exists between Innventure and AeroFlexx (e.g., Innventure founded AeroFlexx and the only AeroFlexx director that is not also an Innventure director is the Chief Executive Officer of AeroFlexx who is, himself, an employee of Innventure). Additionally, based in large part on case law precedent and SEC staff no-action letters, Innventure determined that the loans from Innventure to AeroFlexx should not constitute securities that are "evidences of indebtedness" under the Investment Company Act. Innventure has not requested the SEC to approve this analysis and the SEC has not done so. If the SEC were to disagree with Innventure's analysis or relevant factual circumstances were to change, Innventure may be required to adjust its analysis and, potentially, its asset composition, in order to support its conclusion that it should not be deemed to be an investment company under the Investment Company Act. If Innventure were required to register as an investment company under the Investment Company Act, compliance with the additional associated regulatory burdens would require additional expense and attention from management for which Innventure has not accounted and, furthermore, could require Innventure to restructure its operations, sell certain of its assets or abstain from the purchase of certain assets, which could have a material adverse effect on Innventure's business, financial condition, results of operations and prospects.
- Share Price & Shareholder Rights - Risk 7Provisions in the A&R Certificate of Incorporation and under Delaware law could discourage a takeover that stockholders may consider favorable and may lead to entrenchment of management.
The A&R Certificate of Incorporation and our By-laws (as amended and restated, the "Bylaws") contain provisions that could significantly reduce the value of the Common Stock to a potential acquirer or delay or prevent changes in control or changes in our management without the consent of the Board. The provisions in Innventure's charter documents include the following: - a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of a majority of the Board;- no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;- the exclusive right of the Board, unless the Board grants such a right to the holders of any series of preferred stock, to elect a director to fill a vacancy created by the expansion of the Board or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board;- the prohibition on removal of directors without cause;- the ability of the Board to authorize the issuance of shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;- the ability of the Board to alter the Bylaws without obtaining stockholder approval;- the required approval of at least 2/3 of the shares entitled to vote to amend or repeal the Bylaws or amend, alter or repeal certain provisions of the A&R Certificate of Incorporation;- a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of Innventure's stockholders;- an exclusive forum provision providing that the Court of Chancery of the State of Delaware (the "Delaware Court") will be the exclusive forum for certain actions and proceedings;- the requirement that a special meeting of stockholders may be called only by the Board, Innventure's chief executive officer, or the chairman of the Board, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;- advance notice procedures that stockholders must comply with in order to nominate candidates to the Board or to propose matters to be acted upon at a stockholders' meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer's own slate of directors or otherwise attempting to obtain control of Innventure; and - Innventure is subject to the anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law, which will prevent Innventure from engaging in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other exceptions, the Board has approved the transaction.
- Share Price & Shareholder Rights - Risk 8The market may not fully understand or accept our conglomerate structure and the value of our Innventure Companies, which could cause our common stock to trade at a discount to our net asset value.
We operate as a diversified conglomerate that operates a group of operating businesses across multiple industries. Investors may have difficulty independently assessing the underlying value of our Innventure Companies and our enterprise as a whole. Investors may apply a "conglomerate discount" to our stock price due to perceived complexity of our model, valuation uncertainty, limited liquidity at the subsidiary level, or concerns regarding realization of value. If the market does not fully understand or accept our business model or capital allocation strategy, our common stock may trade at a sustained or significant discount. A sustained discount could impair our ability to raise equity capital on attractive terms, limit our strategic flexibility, reduce the effectiveness of our equity as acquisition currency and increase pressure from stockholders to pursue strategic alternatives transactions such as spin-offs, asset sales, restructurings, or a sale of the company. Such actions, if undertaken, may divert management's attention, increase costs and may not be aligned with our long-term strategic objectives. There can be no assurance that our efforts to demonstrate the intrinsic value of our Innventure Companies will be successful. If our common stock continues to trade at a material discount, our ability to execute our long-term strategy and maximize stockholder value could be materially adversely affected.
- Share Price & Shareholder Rights - Risk 9Stockholder activism or unsolicited acquisition proposals could disrupt our business, divert management's attention and impede our ability to execute our business model and achieve our long-term strategic objectives.
We have, and may from time to time become, subject to stockholder activism, unsolicited acquisition proposals or other attempts to effect changes in our strategic direction, capital allocation priorities, governance structure, management or board composition. Responding to such actions can be costly and time-consuming and may significantly divert the attention and resources of our Board and management from the execution of our business model and long-term strategic initiatives. Stockholder activism campaigns or unsolicited bids may create uncertainty among our employees, customers, suppliers and other business partners. This uncertainty could adversely affect our ability to retain and recruit key personnel, maintain commercial relationships (including with MNCs and Technology Solutions Providers), negotiate contracts, pursue strategic transactions or execute operational initiatives. Public disputes with activist investors or bidders may also result in reputational harm and increased market volatility in our stock price. In addition, addressing activist demands or evaluating unsolicited acquisition proposals may require us to incur substantial advisory, legal and other expenses, including proxy solicitation and public relations costs. If a proxy contest or other contested matter arises, we may experience further distraction and expense. Even if unsuccessful, such actions may lead to changes in strategy or governance that are not aligned with our long-term business plan. If an unsolicited acquisition proposal were to result in a transaction, we may not realize the long-term value of our strategic plan as a standalone company. Alternatively, the perception that we are "in play" may cause stock price volatility and could impair our ability to access capital markets or enter into long-term commercial arrangements. Any of these factors could materially adversely affect our ability to execute our business model, achieve our long-term goals and deliver value to our stockholders.
- Share Price & Shareholder Rights - Risk 10Additional financing transactions by the Innventure Companies could impact your rights as a stockholder of Innventure.
Innventure and the Innventure Companies expect to require additional financing to fund their operations or growth. These additional financing transactions could include transactions at the Innventure Company level, such as Innventure's sale of Innventure Company equity, or the Innventure Companies' issuance of new equity. The issuance of new equity securities to third-party investors at the Innventure Company level or the sale of a portion of Innventure Company equity held by Innventure would reduce Innventure's ownership interest in that Innventure Company. Furthermore, the holders of those equity securities could have structural priority as compared to Common Stock with respect to that Innventure Companies' assets and could also have priority as to liquidation and dividend and other rights more favorable than Common Stock with respect to that Innventure Company. This priority, or any reduction in Innventure's ownership interest in any Innventure Companies, may reduce the value of Common Stock and could impact the Company's ability to refrain from being deemed an investment company under the Investment Company Act .
- Share Price & Shareholder Rights - Risk 11The exclusive forum provision in the A&R Certificate of Incorporation could limit Innventure's stockholders' ability to choose their preferred judicial forum for disputes with Innventure or its directors, officers, or employees.
The A&R Certificate of Incorporation provides that, unless Innventure consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Delaware Court. Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Court in connection with any action to enforce that exclusive forum provision and to service of process in any such action. The exclusive forum provision of the A&R Certificate of Incorporation does not apply to actions arising under federal securities laws including suits brought to enforce any liability or duty created by the Securities Act, the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. To the extent that this provision of the A&R Certificate of Incorporation limits a current or former stockholder's ability to select a judicial forum other than the Delaware Court, it might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses, and might result in outcomes unfavorable to current or former stockholders. A court might determine that this provision of the A&R Certificate of Incorporation is inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on Innventure's reputation, its business operations, and its financial position or results of operations.
- Share Price & Shareholder Rights - Risk 12Volatility in Innventure's share price could subject Innventure to securities class action litigation.
In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. If Innventure faces such litigation, it could result in substantial costs and a diversion of management's attention and resources, which could harm its business.
- Share Price & Shareholder Rights - Risk 13It is not possible to predict the actual number of shares Innventure will sell under the SEPA to Yorkville, or the actual gross proceeds resulting from those sales.
Subject to certain conditions and limitations in the SEPA and compliance with applicable law, Innventure has the discretion to deliver notices to Yorkville at any time throughout the term of the SEPA. The actual number of shares of Common Stock that are issued and sold to Yorkville depends on a number of factors, including the market price of Common Stock during the sales period. Actual gross proceeds may be less than $75.0 million, which may impact Innventure's future liquidity. Because the price per share of each share sold to Yorkville will fluctuate during the sales period, it is not currently possible to predict the number of shares that will be sold or the actual gross proceeds to be raised in connection with those sales. As of March 23, 2026, Innventure has drawn $8.4 million under the SEPA. Moreover, although the SEPA provides that Innventure may sell up to an aggregate of $75.0 million of its Common Stock to Yorkville, Innventure registered the resale by Yorkville of up to 17,242,314 shares of Common Stock that may be issued without exceeding the 9.99% prong of the exchange cap set forth in the SEPA. If Innventure elects to issue and sell to Yorkville all of the shares registered for resale to Yorkville, depending on the market prices of its Common Stock for each purchase made pursuant to the SEPA, the actual gross proceeds from the sale of the shares may be substantially less than the $75.0 million total commitment available to Innventure under the SEPA. If it becomes (i) necessary for Innventure to issue and sell to Yorkville under the SEPA more shares than the shares registered for resale by Yorkville in order to receive the aggregate gross proceeds equal to $75.0 million under the SEPA and (ii) if Innventure is able to sell more shares than the shares registered for resale by Yorkville while still complying with the exchange cap, then Innventure will need to file with the SEC one or more additional registration statements to register under the Securities Act of 1933, as amended (the "Securities Act") the resale by Yorkville of any such additional shares of Common Stock over the shares registered for resale by Yorkville and such registration statements would need to be declared effective by the SEC, in each case before Innventure may elect to sell any additional shares of Common Stock to Yorkville under the SEPA, a process which will take time and incur additional expense. Any issuance and sale by Innventure under the SEPA of a substantial amount of shares of Common Stock in addition to the shares already registered for resale by Yorkville could cause additional substantial dilution to Innventure's stockholders. The number of shares of Common Stock ultimately offered for resale by Yorkville is dependent upon the number of shares of Common Stock, if any, Innventure ultimately sells to Yorkville under the SEPA.
- Share Price & Shareholder Rights - Risk 14It is not possible to predict the extent to which Innventure will, intends to, or may rely on Yorkville and the SEPA as a source of funding or the actual number of shares Innventure will sell or gross proceeds resulting from those sales.
Subject to the terms and conditions of the SEPA, Innventure may, at its discretion, issue and sell to Yorkville up to $75.0 million of shares of Common Stock from time to time. As of March 23, 2026, Innventure has drawn $2.67 million under the SEPA. The purchase price per share will fluctuate based on the market prices of Common Stock during the sales period, and Innventure has the discretion to deliver notices to Yorkville at any time throughout the term of the SEPA, subject to certain conditions and limitations in the SEPA and compliance with applicable law. Accordingly, it is not currently possible to predict the number of shares that will be issued and sold to Yorkville, the actual purchase price per share to be paid by Yorkville for those shares or the actual gross proceeds to be raised in connection with those sales. Actual gross proceeds may be less than $75.0 million, which may impact Innventure's future liquidity. Moreover, although the SEPA provides that Innventure may sell up to an aggregate of $75.0 million of its Common Stock to Yorkville, Innventure registered the resale by Yorkville of up to 16,244,741 shares of Common Stock that may be issued subject to certain ownership limitations set forth in the SEPA. If Innventure elects to issue and sell to Yorkville all of the shares registered for resale, depending on the market prices of its Common Stock for each purchase made pursuant to the SEPA, the actual gross proceeds from the sale of those shares may be substantially less than the remaining approximately $66.6 million total commitment available under the SEPA. If (i) it becomes necessary for Innventure to issue and sell to Yorkville more shares than the shares registered for resale in order to receive aggregate gross proceeds equal to the remaining approximately $66.6 million under the SEPA and (ii) if Innventure is able to sell more shares than the shares registered for resale by Yorkville while still complying with the ownership limitations set forth in the SEPA, then Innventure will need to file with the SEC one or more additional registration statements to register under the Securities Act of 1933, as amended (the "Securities Act") the resale by Yorkville of any such additional shares of Common Stock, and such registration statements would need to be declared effective by the SEC, in each case before Innventure may elect to sell any additional shares to Yorkville under the SEPA, a process which will take time and incur additional expense. Any issuance and sale by Innventure under the SEPA of a substantial amount of shares of Common Stock in addition to the shares already registered for resale by Yorkville could cause additional substantial dilution to Innventure's stockholders. The number of shares of Common Stock ultimately offered for resale by Yorkville is dependent upon the number of shares, if any, Innventure ultimately sells to Yorkville under the SEPA. The extent to which Innventure will rely on Yorkville as a source of funding will depend on a number of factors, including the prevailing market price of Common Stock and the extent to which Innventure is able to secure working and other capital from other sources. If obtaining sufficient funding from Yorkville were to prove unavailable or prohibitively dilutive, Innventure may need to secure additional sources of funding beyond its current expectations in order to satisfy its working and other capital needs. Even if Innventure were to sell to Yorkville all of the shares of Common Stock available for sale under the SEPA, Innventure may still need additional capital to fully implement its business, operating and development plans. Should the financing Innventure requires to sustain its working capital needs be unavailable or prohibitively expensive when Innventure requires it, the consequences may be a material adverse effect on Innventure's business, operating results, financial condition and prospects.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.

